ClinicalTrials.govpublic full text
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
carcinoma, non-small-cell lung, non-small-cell lung cancer, nsclc, non-squamous, genomics, guided therapy, directed therapy, genomic expression profiles, chemotherapy sensitivity, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804686
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.